These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7064188)

  • 21. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
    Barnathan ES; Schwartz JS; Taylor L; Laskey WK; Kleaveland JP; Kussmaul WG; Hirshfeld JW
    Circulation; 1987 Jul; 76(1):125-34. PubMed ID: 2954724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
    Rote WE; Nedelman MA; Mu DX; Manley PJ; Weisman H; Cunningham MR; Lucchesi BR
    Stroke; 1994 Jun; 25(6):1223-32; discussion 1233. PubMed ID: 8202985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals.
    Iomhair MM; Lavelle SM
    Thromb Res; 1996 Jun; 82(6):479-83. PubMed ID: 8794520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease.
    Rowe GG; Folts JD
    Clin Cardiol; 1990 Mar; 13(3):165-70. PubMed ID: 2182246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cell damage and thrombus formation following temporary arterial occlusion. Effects of pretreatment with aspirin or heparin.
    Gertz SD; Kurgan A; Wajnberg RS; Nelson E
    J Neurosurg; 1979 May; 50(5):578-86. PubMed ID: 430151
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
    Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Castillo-Olivares JL
    Rev Esp Cardiol; 1989 Oct; 42(8):536-40. PubMed ID: 2602610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.
    Beckett VL; Conn DL; Fuster V; Osmundson PJ; Strong CG; Chao EY; Chesebro JH; O'Fallon WM
    Arthritis Rheum; 1984 Oct; 27(10):1137-43. PubMed ID: 6386002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction.
    Johannessen KA; Stratton JR; Taulow E; Osterud B; von der Lippe G
    Am J Cardiol; 1989 Jan; 63(1):101-2. PubMed ID: 2642365
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of flunarizine on arterial thrombosis after endarterectomy in rats.
    Kobayashi H; Hayashi M; Kawano H; Handa Y; Kabuto M; Kobayashi S
    Neurol Med Chir (Tokyo); 1989 Jul; 29(7):563-7. PubMed ID: 2477752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
    Adams JH; Mitchell JR
    Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
    George CR; Slichter SJ; Quadracci LJ; Kenny GM; Dennis MB; Striker GE; Harker LA
    Transplantation; 1975 Sep; 20(3):237-40. PubMed ID: 1099729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
    Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
    N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
    Ostendorf P
    Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
    Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates.
    Harker LA; Kelly AB; Hanson SR; Krupski W; Bass A; Osterud B; FitzGerald GA; Goodnight SH; Connor WE
    Circulation; 1993 Mar; 87(3):1017-29. PubMed ID: 8443878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete patency in thrombus-occluded arteries two weeks after laser recanalization.
    Marco J; Silvernail PJ; Fournial G; Choy DS; Fajadet J; Case RB
    Lasers Surg Med; 1985; 5(3):291-6. PubMed ID: 4010440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
    Bollinger A; Brunner U
    Vasa; 1985; 14(3):272-9. PubMed ID: 4050068
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
    Hupkens P; Cooley BC
    Microsurgery; 1996; 17(4):226-9. PubMed ID: 9140956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
    Edmondson RA; Cohen AT; Das SK; Wagner MB; Kakkar VV
    Lancet; 1994 Oct; 344(8927):914-8. PubMed ID: 7934346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.